"10.1371_journal.pone.0072329","plos one","2013-08-22T00:00:00Z","Yeshi Yin; T Ryan Withers; Xin Wang; Hongwei D Yu","Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine at Marshall University, Huntington, West Virginia, United States of America; Department of Pediatrics, Joan C. Edwards School of Medicine at Marshall University, Huntington, West Virginia, United States of America; Institute of Plant Protection and Microbiology, Zhejiang Academy of Agricultural Sciences, Hangzhou, China; Progenesis Technologies, LLC, Huntington, West Virginia, United States of America","Conceived and designed the experiments: YY HDY. Performed the experiments: YY TRW. Analyzed the data: YY TRW HDY. Wrote the paper: YY TRW XW HDY.","The authors declare that Hongwei D. Yu is the co-founder and Chief Science Officer of Progenesis Technologies, LLC (www.progenesistech.com), a biotech start-up company located in Huntington, West Virginia. Progenesis Technologies develops the recombinant alginate using the genetically modified bacteria as the sources. There is one issued patent (U.S. Patent No. 7,781,166) and one pending patent (application No. 61/048,858) that cover the technologies. Up till now, H.D.Y. hasnt received financial compensation from Progeneis Technologies. Publication of this paper does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Yeshi Yin","YY",4,TRUE,2,2,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
